Cargando…

Decreased bone turnover in HIV-infected children on antiretroviral therapy

SUMMARY: In this study, we evaluated the relationships between immune activation, bone turnover, and bone mass in virally suppressed HIV-infected children and HIV-uninfected children in South Africa. We found that decreased bone mass may occur or persist independent of immune activation and altered...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiau, Stephanie, Yin, Michael T., Strehlau, Renate, Patel, Faeezah, Mbete, Ndileka, Kuhn, Louise, Coovadia, Ashraf, Arpadi, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886991/
https://www.ncbi.nlm.nih.gov/pubmed/29623447
http://dx.doi.org/10.1007/s11657-018-0452-6
_version_ 1783312204416679936
author Shiau, Stephanie
Yin, Michael T.
Strehlau, Renate
Patel, Faeezah
Mbete, Ndileka
Kuhn, Louise
Coovadia, Ashraf
Arpadi, Stephen M.
author_facet Shiau, Stephanie
Yin, Michael T.
Strehlau, Renate
Patel, Faeezah
Mbete, Ndileka
Kuhn, Louise
Coovadia, Ashraf
Arpadi, Stephen M.
author_sort Shiau, Stephanie
collection PubMed
description SUMMARY: In this study, we evaluated the relationships between immune activation, bone turnover, and bone mass in virally suppressed HIV-infected children and HIV-uninfected children in South Africa. We found that decreased bone mass may occur or persist independent of immune activation and altered bone turnover. PURPOSE: HIV-infected children and adolescents have deficits in skeletal growth which include decreases in bone mass and alterations in bone microarchitecture. However, the mechanism by which HIV infection compromises bone accrual in children and adolescents is unclear. The goal of this study was to evaluate the relationships between immune activation, bone turnover, and bone mass in a group of pre-pubertal HIV-infected children randomized to remain on ritonavir-boosted lopinavir (LPV/r)-based antiretroviral therapy (ART) or switch to efavirenz-based ART in South Africa virally suppressed at the time of this study. METHODS: This cross-sectional analysis included 219 HIV-infected and 180 HIV-uninfected children enrolled in the CHANGES Bone Study conducted in Johannesburg, South Africa. Whole body (WB) bone mineral content (BMC) was assessed by dual x-ray absorptiometry and WB BMC Z-scores adjusted for sex, age, and height were generated. Bone turnover markers, including C-telopeptide of type 1 collagen (CTx) and procollagen type I N-terminal propeptide (P1NP), were analyzed. Markers of immune activation were also measured, including cytokines IL-6 and TNF-alpha, as well as soluble CD14 and high-sensitivity C-reactive protein (CRP). RESULTS: Compared to uninfected controls, HIV-infected children had lower WB BMC Z-scores, similar IL-6 and TNF-alpha, higher soluble CD14 and high-sensitivity CRP, and lower markers of bone resorption (CTX) and bone formation (P1NP). Bone turnover markers were not different in those remaining on LPV/r or switched to efavirenz. CONCLUSIONS: Our findings suggest that in HIV-infected children with viral suppression, decreased bone accrual may occur or persist independent of immune activation and altered bone turnover.
format Online
Article
Text
id pubmed-5886991
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-58869912018-04-12 Decreased bone turnover in HIV-infected children on antiretroviral therapy Shiau, Stephanie Yin, Michael T. Strehlau, Renate Patel, Faeezah Mbete, Ndileka Kuhn, Louise Coovadia, Ashraf Arpadi, Stephen M. Arch Osteoporos Original Article SUMMARY: In this study, we evaluated the relationships between immune activation, bone turnover, and bone mass in virally suppressed HIV-infected children and HIV-uninfected children in South Africa. We found that decreased bone mass may occur or persist independent of immune activation and altered bone turnover. PURPOSE: HIV-infected children and adolescents have deficits in skeletal growth which include decreases in bone mass and alterations in bone microarchitecture. However, the mechanism by which HIV infection compromises bone accrual in children and adolescents is unclear. The goal of this study was to evaluate the relationships between immune activation, bone turnover, and bone mass in a group of pre-pubertal HIV-infected children randomized to remain on ritonavir-boosted lopinavir (LPV/r)-based antiretroviral therapy (ART) or switch to efavirenz-based ART in South Africa virally suppressed at the time of this study. METHODS: This cross-sectional analysis included 219 HIV-infected and 180 HIV-uninfected children enrolled in the CHANGES Bone Study conducted in Johannesburg, South Africa. Whole body (WB) bone mineral content (BMC) was assessed by dual x-ray absorptiometry and WB BMC Z-scores adjusted for sex, age, and height were generated. Bone turnover markers, including C-telopeptide of type 1 collagen (CTx) and procollagen type I N-terminal propeptide (P1NP), were analyzed. Markers of immune activation were also measured, including cytokines IL-6 and TNF-alpha, as well as soluble CD14 and high-sensitivity C-reactive protein (CRP). RESULTS: Compared to uninfected controls, HIV-infected children had lower WB BMC Z-scores, similar IL-6 and TNF-alpha, higher soluble CD14 and high-sensitivity CRP, and lower markers of bone resorption (CTX) and bone formation (P1NP). Bone turnover markers were not different in those remaining on LPV/r or switched to efavirenz. CONCLUSIONS: Our findings suggest that in HIV-infected children with viral suppression, decreased bone accrual may occur or persist independent of immune activation and altered bone turnover. Springer London 2018-04-05 2018 /pmc/articles/PMC5886991/ /pubmed/29623447 http://dx.doi.org/10.1007/s11657-018-0452-6 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Shiau, Stephanie
Yin, Michael T.
Strehlau, Renate
Patel, Faeezah
Mbete, Ndileka
Kuhn, Louise
Coovadia, Ashraf
Arpadi, Stephen M.
Decreased bone turnover in HIV-infected children on antiretroviral therapy
title Decreased bone turnover in HIV-infected children on antiretroviral therapy
title_full Decreased bone turnover in HIV-infected children on antiretroviral therapy
title_fullStr Decreased bone turnover in HIV-infected children on antiretroviral therapy
title_full_unstemmed Decreased bone turnover in HIV-infected children on antiretroviral therapy
title_short Decreased bone turnover in HIV-infected children on antiretroviral therapy
title_sort decreased bone turnover in hiv-infected children on antiretroviral therapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886991/
https://www.ncbi.nlm.nih.gov/pubmed/29623447
http://dx.doi.org/10.1007/s11657-018-0452-6
work_keys_str_mv AT shiaustephanie decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy
AT yinmichaelt decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy
AT strehlaurenate decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy
AT patelfaeezah decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy
AT mbetendileka decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy
AT kuhnlouise decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy
AT coovadiaashraf decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy
AT arpadistephenm decreasedboneturnoverinhivinfectedchildrenonantiretroviraltherapy